The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a phase 1b study of fruquintinib plus sintilimab in advanced colorectal cancer.
 
Ye Guo
Research Funding - Hutchison MediPharma; Innovent Biologics, Inc
 
Weijie Zhang
No Relationships to Disclose
 
Jieer Ying
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Wensheng Qiu
No Relationships to Disclose
 
Weiguo Su
Employment - Hutchison MediPharma
 
Panfeng Tan
Employment - Hutchison MediPharma
 
Hongyan Yin
Employment - Hutchison MediPharma
 
Yan Wang
Employment - Innovent Biologics
 
Yang Luo
Employment - Innovent Biologics
 
Hui Zhou
Employment - Innovent Biologics
 
Jin Li
No Relationships to Disclose